Single anticoagulant blood thinner after stent in atrial fibrillation
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether taking a single “P2Y12 inhibitor” blood thinner (instead of multiple medicines) is safe and effective after you get a coronary stent. It’s for people with atrial fibrillation who need long-term blood thinning and have recently had a successful stent procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older
- You have atrial fibrillation or flutter and need long-term blood thinners you take by mouth (DOACs) for at least 12 months
- You had a successful heart stent procedure within the last 7 days, and there are no other planned lesions to treat
- You had no major complications right after the stent (no suspected heart-attack chest pain, stent clot, or new neurologic symptoms)
- You can sign a consent form, and you’re not planning certain heart rhythm procedures or staged stent procedures soon
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a rhythm-guided approach to using blood thinners (antithrombotics) is safe and effective for people who have had both a heart stent and a successful ablation for atrial fibrillation. It may help you avoid unnecessary medication while preventing strokes and bleeds.
This trial tests if a very short course of dual antiplatelet therapy (two blood thinners) after getting a stent is safe and effective for patients aged 65 and older. The goal is to reduce bleeding risks while still preventing heart attacks.
This trial tests whether taking just one blood thinner (clopidogrel) is as safe and effective as taking two (clopidogrel plus aspirin) for older adults or people at high bleeding risk who have had a drug-coated balloon procedure to open blocked heart arteries.
This study compares different blood-thinner (“antithrombotic”) strategies in people with atrial fibrillation or flutter who recently had a stent placed (PCI). It aims to find a plan that lowers clot risk while keeping bleeding risk as low as possible.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This trial tests whether patients who have had a heart attack or unstable angina and a stent placed with ultrasound guidance can safely stop one of their blood-thinning medicines early. It helps doctors find the best way to prevent future heart problems with fewer side effects.
Hear when a new Oral Anticoagulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.